What does CUSIP 629444950 represent in this 13F holders report?

CUSIP 629444950 is the security identifier for 629444950 - NRX PHARMACEUTICALS INC - COM - Put used to aggregate holder disclosures.

How many institutions held 629444950 - NRX PHARMACEUTICALS INC - COM - Put in Q3 2023?

No institutional holders were reported for 629444950 - NRX PHARMACEUTICALS INC - COM - Put in Q3 2023; review adjacent reporting periods for trend context.

NRX PHARMACEUTICALS INC - COM - Put

CUSIP: 629444950

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class: Equity / COM
Number of holders: 0

Quarterly Holders Quick Answers

What is CUSIP 629444950?
CUSIP 629444950 identifies 629444950 - NRX PHARMACEUTICALS INC - COM - Put in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2024
Previous quarter: Q2 2023

Recent filing periods for CUSIP 629444950:

Q2 2024 Q1 2024 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022

NRX PHARMACEUTICALS INC - COM - Put

Q3 2023 13F Holders as of 30 Sep 2023

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of NRX PHARMACEUTICALS INC - COM - Put as of Q3 2023.